- Home
- JZXN vs INDP Comparison
JZXN vs INDP Comparison
Compare JZXN & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- INDP
- Stock Information
- Founded
- JZXN 2019
- INDP 2000
- Country
- JZXN China
- INDP United States
- Employees
- JZXN N/A
- INDP N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- INDP Biotechnology: Pharmaceutical Preparations
- Sector
- JZXN Consumer Discretionary
- INDP Health Care
- Exchange
- JZXN Nasdaq
- INDP Nasdaq
- Market Cap
- JZXN 51.8M
- INDP 6.0M
- IPO Year
- JZXN 2021
- INDP N/A
- Fundamental
- Price
- JZXN $1.04
- INDP $2.28
- Analyst Decision
- JZXN
- INDP Strong Buy
- Analyst Count
- JZXN 0
- INDP 2
- Target Price
- JZXN N/A
- INDP $238.00
- AVG Volume (30 Days)
- JZXN 247.0K
- INDP 193.3K
- Earning Date
- JZXN 03-05-2026
- INDP 11-11-2025
- Dividend Yield
- JZXN N/A
- INDP N/A
- EPS Growth
- JZXN N/A
- INDP N/A
- EPS
- JZXN N/A
- INDP N/A
- Revenue
- JZXN $97,465.00
- INDP N/A
- Revenue This Year
- JZXN N/A
- INDP N/A
- Revenue Next Year
- JZXN N/A
- INDP N/A
- P/E Ratio
- JZXN N/A
- INDP N/A
- Revenue Growth
- JZXN N/A
- INDP N/A
- 52 Week Low
- JZXN $0.78
- INDP $2.26
- 52 Week High
- JZXN $7.82
- INDP $58.24
- Technical
- Relative Strength Index (RSI)
- JZXN 58.75
- INDP 20.16
- Support Level
- JZXN $0.78
- INDP $2.34
- Resistance Level
- JZXN $1.12
- INDP $2.86
- Average True Range (ATR)
- JZXN 0.07
- INDP 0.69
- MACD
- JZXN 0.04
- INDP -0.24
- Stochastic Oscillator
- JZXN 76.47
- INDP 1.22
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its operating segments are propretaey product; and resale of sourced Equipment and accessories from third party products. The company generates a majority of its revenue from the propretaey product segment. Geographically, the firm operates in China.
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.